Under a new Biden administration plan, the Federal Emergency Management Agency could operate up to 100 mass vaccination sites. “Concept of Operations,” a new draft document notes that FEMA would aim to support community vaccination centers, with some of its sites providing up to 6,000 doses per day. (The Washington Post)
The Food and Drug Administration has approved monthly shots to treat H.I.V., giving patients an alternative to daily pills. The treatment, ViiV Healthcare’s Cabenuva, was shown to suppress H.I.V. to undetectable levels. (The New York Times)
Up to 20% of counties in the U.S. – encompassing around seven million people – lack a single COVID-19 testing site, according to new data. Many of those “testing deserts” are in low-income areas. (The Wall Street Journal)
Charlie Fuchs, director of the Yale Cancer Center and physician-in-chief at Smilow Cancer Hospital, will be joining Roche/Genentech. Fuchs will serve as global development chief, a role in which he’ll lead the company’s oncology and hematology initiatives. (Endpoints News)
Pfizer said it will provide up to 40 million doses of its COVID-19 vaccine to Covax, a global immunization program co-led by the World Health Organization. The program aims to expand vaccination in low-to-middle-income nations. (CNBC Weekly)
